Kiyozumi Yuki, Yoshida Naoya, Ishimoto Takatsugu, Yagi Taisuke, Koga Yuki, Uchihara Tomoyuki, Sawayama Hiroshi, Hiyoshi Yukiharu, Iwatsuki Masaaki, Baba Yoshifumi, Miyamoto Yuji, Watanabe Masayuki, Matsuyama Tomohiko, Oya Natsuo, Baba Hideo
Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
Department of Gastroenterological Surgery, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
World J Surg. 2018 Sep;42(9):2887-2893. doi: 10.1007/s00268-018-4536-7.
The aim of this study was to confirm prognostic factors for salvage esophagectomy for remnant or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy.
We retrospectively analyzed clinicopathological backgrounds of 50 patients who underwent salvage esophagectomy between April 2005 and January 2016. Salvage esophagectomy comprised 40 three-incision esophagectomies, two transhiatal esophagectomies and eight pharyngolaryngoesophagectomies. Independent prognostic factors for overall survival were assessed using Cox regression analysis of the factors.
Salvage esophagectomy remains a highly invasive surgery and correlated with a higher incidence of all morbidities of Clavien-Dindo classification (CDc) ≥II, severe morbidities of CDc ≥ IIIb, any pulmonary morbidities and chylorrhea, compared with those in patients without preoperative definitive chemoradiotherapy. Cox regression analysis suggested that R0 resection (hazard ratio [HR] 6.39; 95% confidence interval [CI] 2.03-9.68, P = 0.002), absence of severe complications (HR 4.97; 95% CI 1.70-14.81, P = 0.004) and early pStage (0-II) (HR 3.42; 95% CI 1.24-10.12, P = 0.018) were independent prognostic factors for salvage esophagectomy.
Salvage esophagectomy remains correlated with a high incidence of postoperative complications. Avoiding non-curative surgery and reducing the incidence of severe postoperative complications are important if patients are to receive prognostic benefit of this highly invasive surgery.
本研究旨在确定接受根治性放化疗后残留或复发性食管鳞状细胞癌挽救性食管切除术的预后因素。
我们回顾性分析了2005年4月至2016年1月期间接受挽救性食管切除术的50例患者的临床病理背景。挽救性食管切除术包括40例三切口食管切除术、2例经裂孔食管切除术和8例咽-喉-食管切除术。使用这些因素的Cox回归分析评估总生存的独立预后因素。
与术前未接受根治性放化疗的患者相比,挽救性食管切除术仍然是一种高侵入性手术,且与Clavien-Dindo分类(CDc)≥II级的所有并发症、CDc≥IIIb级的严重并发症、任何肺部并发症和乳糜胸的发生率较高相关。Cox回归分析表明,R0切除(风险比[HR]6.39;95%置信区间[CI]2.03 - 9.68,P = 0.002)、无严重并发症(HR 4.97;95% CI 1.70 - 14.81,P = 0.004)和早期p分期(0 - II期)(HR 3.42;95% CI 1.24 - 10.12,P = 0.018)是挽救性食管切除术的独立预后因素。
挽救性食管切除术仍然与术后并发症的高发生率相关。如果患者要从这种高侵入性手术中获得预后益处,避免非根治性手术并降低术后严重并发症的发生率很重要。